USPSTF Recommends Against Screening for COPD in Asymptomatic Adults

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MAY 10, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.5692?guestAccessKey=c6636bea-bc7e-4706-8242-b2c8348eaf61&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051022

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends against screening for chronic obstructive pulmonary disease (COPD) in asymptomatic adults who do not recognize or report respiratory symptoms. Chronic obstructive pulmonary disease is an irreversible reduction of airflow in the lungs. Progression to severe disease can prevent participation in normal activities because of deterioration of lung function. In 2020 it was estimated that approximately 6% of U.S. adults had been diagnosed with COPD. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement is a reaffirmation of its 2016 recommendation statement.

 

(doi:10.1001/jama.2022.5692)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.